Sartorius | SRT3 - Ebitda

Stock Price
204.90
Daily Change
-8.60 -4.03%
Monthly
-10.13%
Yearly
-11.22%
Q2 Forecast
211.37

Sartorius reported EUR267.3M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
Moderna USD -790M 582M Dec/2025
Organon & Co USD 415M 32M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Sartorius EUR 267.3M 10.1M Mar/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.05B 46.4M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025